Cargando…

Benefit-risk assessment for remdesivir in COVID-19

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290138/ http://dx.doi.org/10.1007/s40278-020-79483-8

Ejemplares similares

Remdesivir use in severe renal impairment: benefits outweigh risks
Publicado: (2021)

Baricitinib + remdesivir cost saving vs remdesivir for hospitalised COVID-19 patients in the USA
Publicado: (2021)

Remdesivir does not increase risk of AKI or ALI in COVID-19 patients
Publicado: (2022)

Remdesivir cost effective for severe COVID-19 in China
Publicado: (2021)

Quality of ADR reporting evaluated for remdesivir trials of COVID-19
Publicado: (2020)

Remdesivir vs tocilizumab in COVID-19: adverse event profiles
Publicado: (2021)

Remdesivir in Treatment of COVID-19: A Systematic Benefit–Risk Assessment
por: Davies, Miranda, et al.
Publicado: (2020)

Effects on LOS may not justify cost of remdesivir for severe COVID-19
Publicado: (2021)

Remdesivir may be cost saving in eligible patients during COVID-19 infections in Germany
Publicado: (2021)

Protocol: Benefits and harms of remdesivir for COVID-19 in adults: A systematic review with meta-analysis
por: Paludan-Müller, Asger Sand, et al.
Publicado: (2021)

Remdesivir appears to save costs in COVID-19 patients on low-flow oxygen therapy in Turkey
Publicado: (2021)

Remdesivir and COVID-19 infection, therapeutic benefits or unnecessary risks?
por: Vitiello, Antonio, et al.
Publicado: (2021)

Risk-benefit of AstraZeneca COVID-19 vaccination in Australia
Publicado: (2021)

Cost-benefit of COVID-19 lockdown in the UK
Publicado: (2020)

Comparing the efficacy of regen-cov, remdesivir, and favipiravir in reducing invasive mechanical ventilation need in hospitalized COVID-19 patients
por: Hegazy, Sahar Kmal, et al.
Publicado: (2023)

Use and Safety of Remdesivir in Kidney Transplant Recipients With COVID-19
por: Buxeda, Anna, et al.
Publicado: (2021)

REMDESIVIR-INDUCED EXTREME SINUS BRADYCARDIA IN COVID-19
por: Hamilton, Steven A., et al.
Publicado: (2022)

Efficacy of remdesivir for hospitalized COVID-19 patients with end stage renal disease
por: Selvaraj, Vijairam, et al.
Publicado: (2022)

Mortality Benefit of Remdesivir in COVID-19: A Systematic Review and Meta-Analysis
por: Bansal, Vikas, et al.
Publicado: (2021)

Remdesivir and COVID-19
por: Ferrara, Francesco, et al.
Publicado: (2020)

Remdesivir for COVID-19
Publicado: (2020)

Remdesivir and COVID-19
por: Glaus, Matthew J, et al.
Publicado: (2020)

Remdesivir and COVID-19
por: Wang, Lei-Yun, et al.
Publicado: (2020)

Remdesivir and COVID-19
por: Dennis, Alicia
Publicado: (2020)

Remdesivir and COVID-19
por: Edwards, Jessie K, et al.
Publicado: (2020)

Assessing the benefit–risk of new treatments using generalised pairwise comparisons: the case of erlotinib in pancreatic cancer
por: Péron, J, et al.
Publicado: (2015)

In silico evidence of Remdesivir action in blood coagulation cascade modulation in COVID-19 treatment
por: Pagliarin, Luis Gustavo, et al.
Publicado: (2023)

Use of Remdesivir in Patients With COVID-19 on Hemodialysis: A Study of Safety and Tolerance
por: Aiswarya, Dhanapalan, et al.
Publicado: (2020)

Potential Effects of Remdesivir on Tacrolimus Exposure in Transplant Recipients With COVID-19 Infection
por: Habeeb, Ehsan, et al.
Publicado: (2023)

Best COVID-19 vaccine allocation strategy using a net-monetary benefit approach?
Publicado: (2021)

Association of Treatment with Remdesivir and 30-day Hospital Readmissions in Patients Hospitalized with COVID-19
por: Finn, Arkadiy, et al.
Publicado: (2022)

Remdesivir for patients with COVID-19
por: Wu, Peter E., et al.
Publicado: (2021)

REMDESIVIR USE AND TRANSIENT COMPLETE ATRIOVENTRICULAR BLOCK IN THE COVID19 POSITIVE PATIENT
por: Hossain, Afif, et al.
Publicado: (2023)

Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Aditional Benefit
por: Sun, Duxin
Publicado: (2020)

Assessing the evidence on remdesivir
por: Núñez, Isaac, et al.
Publicado: (2021)

Assessing the evidence on remdesivir
por: Trøseid, Marius, et al.
Publicado: (2021)

Risks and neurological benefits of meningioma surgery in elderly patients compared to young patients
por: Ahmeti, Hajrullah, et al.
Publicado: (2021)

REMDESIVIR CAUSING PROFOUND BRADYCARDIA
por: Sneij, Eliea, et al.
Publicado: (2021)

Remdesivir and COVID-19 – Authors' reply
por: Wang, Yeming, et al.
Publicado: (2020)

To Determine the Efficacy of Remdesivir in Covid-19
por: Hameed, A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nb0s9fr38l6vi61vl19pcaaq1n